Free Trial

Outlook Therapeutics (OTLK) SEC Filings & 10K Form

Outlook Therapeutics logo
$2.02 +0.03 (+1.51%)
Closing price 04:00 PM Eastern
Extended Trading
$2.01 -0.01 (-0.69%)
As of 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Outlook Therapeutics SEC Filings

DateFilerForm TypeView
01/27/2025
4:04 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/23/2025
4:00 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 10-K/A
01/22/2025
3:17 PM
GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Form SCHEDULE 13D/A
01/16/2025
4:16 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
3:30 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/27/2024
7:14 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
3:11 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2024
6:27 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
11:26 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:55 PM
GREAT POINT PARTNERS LLC (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Form SC 13G/A
10/03/2024
8:22 PM
Gangolli Julian S (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
THURMAN RANDY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
HILZINGER KURT J (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Auffarth Gerd (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Haller Julia A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:53 PM
KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:48 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
7:41 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
6:25 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form DEF 14A
05/15/2024
4:19 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
11:15 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
05/01/2024
5:02 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:18 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/17/2024
8:38 PM
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Syntone Ventures LLC (Filed by)
Form SC 13D/A
04/17/2024
7:21 PM
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Syntone Ventures LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
4:21 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
04/15/2024
3:53 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
3:27 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 424B5
04/07/2024
11:15 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
04/02/2024
3:15 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
11:15 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
04/01/2024
3:53 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 424B3
03/29/2024
1:16 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
03/29/2024
9:39 AM
Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:00 PM
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
03/26/2024
3:20 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:11 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/22/2024
4:00 PM
KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Is this the pin that pops the bubble? (Ad)

CEO Jensen Huang does not want you knowing this dirty little secret about Nvidia… In fact, any day now we’re expecting a cease and desist from Nvidia’s lawyers. Go here now before it’s too late to find out why Nvidia shares are slumping so hard.

03/22/2024
4:00 PM
Evanson Jeff (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:00 PM
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
TRENARY C RUSSELL III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
4:24 PM
GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Form SC 13D/A
03/20/2024
4:20 PM
GMS Ventures & Investments (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Ghiath M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:14 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
3:43 PM
Evanson Jeff (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:18 PM
Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
5:59 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form DEF 14A
02/08/2024
6:00 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form ARS
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OTLK) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners